These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 18808768)

  • 1. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
    Gabelle A; Roche S; Lehmann S
    Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
    Cedazo-Minguez A; Winblad B
    Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF proteome: a protein repository for potential biomarker identification.
    Romeo MJ; Espina V; Lowenthal M; Espina BH; Petricoin EF; Liotta LA
    Expert Rev Proteomics; 2005 Jan; 2(1):57-70. PubMed ID: 15966853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases.
    Verbeek MM; De Jong D; Kremer HP
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):25-40. PubMed ID: 12542908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.
    Blennow K
    Expert Rev Mol Diagn; 2005 Sep; 5(5):661-72. PubMed ID: 16149870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
    D'Ascenzo M; Relkin NR; Lee KH
    Curr Opin Mol Ther; 2005 Dec; 7(6):557-64. PubMed ID: 16372405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical dementia diagnostics: State of the art and research perspectives.
    Lewczuk P; Wiltfang J
    Proteomics; 2008 Mar; 8(6):1292-301. PubMed ID: 18271068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.
    Choi YS; Choe LH; Lee KH
    Expert Rev Proteomics; 2010 Dec; 7(6):919-29. PubMed ID: 21142892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical proteomics in neurodegenerative disorders.
    Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
    Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.
    Tumani H; Teunissen C; Süssmuth S; Otto M; Ludolph AC; Brettschneider J
    Expert Rev Mol Diagn; 2008 Jul; 8(4):479-94. PubMed ID: 18598229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteome studies of CSF in AD patients.
    Davidsson P; Sjögren M
    Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
    Maurer MH
    Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical biomarkers in the differential diagnosis of movement disorders.
    Mollenhauer B; Trenkwalder C
    Mov Disord; 2009 Jul; 24(10):1411-26. PubMed ID: 19412961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.
    Otto M; Lewczuk P; Wiltfang J
    Methods; 2008 Apr; 44(4):289-98. PubMed ID: 18374272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF-studies in neuropsychiatric disorders.
    Raedler TJ; Wiedemann K
    Neuro Endocrinol Lett; 2006 Jun; 27(3):297-305. PubMed ID: 16807525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes.
    Strekalova H; Buhmann C; Kleene R; Eggers C; Saffell J; Hemperly J; Weiller C; Müller-Thomsen T; Schachner M
    Neurobiol Aging; 2006 Jan; 27(1):1-9. PubMed ID: 16298234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
    Brettschneider J; Widl K; Ehrenreich H; Riepe M; Tumani H
    Neurosci Lett; 2006 Sep; 404(3):347-51. PubMed ID: 16815630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of Alzheimer's disease in body fluids.
    Zheng Y; He J; Hong T
    Sci China Life Sci; 2010 Apr; 53(4):490-6. PubMed ID: 20596916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.